언어선택 ENG
전체메뉴

News

Innovative Medicines based on
ImmunoModulatory Biologics

(November 20, 2020) IMBiologics inks a worldwide exclusive licensing deal for anti-OX40L/TNF BsAb

  • Date
    2022-03-07 12:13:43
  • View
    275


For more information, please visit : IMBiologics News (full article available in Korean)